Arnaud Marchand

2.7k citations

58 papers · 1.5k indexed · h-index 17

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 11
- HIV Research and Treatment 9
Infectious Diseases 26
- HIV/AIDS drug development and treatment 13
- Antifungal resistance and susceptibility 4

Co-authors: Patrick Chaltin Frauke Christ Zeger Debyser Belete A. Desimmie Dorothée Bardiot Karin Thevissen Bruno P.A. Cammue Arnout Voet
Journals: Antiviral Research (6 papers)Nucleosides Nucleotides & Nucleic Acids (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)
Partner nations: Belgium France United Kingdom

In The Last Decade

Arnaud Marchand

50 papers receiving 1.5k citations

Peers

Countries citing papers authored by Arnaud Marchand

Since Specialization

Citations

This map shows the geographic impact of Arnaud Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Marchand more than expected).

Fields of papers citing papers by Arnaud Marchand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Marchand. The network helps show where Arnaud Marchand may publish in the future.

Co-authors

The 25 scholars most cited alongside Arnaud Marchand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnaud Marchand Line = papers co-authored together Arnaud Marchand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High-throughput split-GFP antiviral screening assay against fusogenic paramyxoviruses Antiviral Research ·Laura Vandemaele, W. Wayne Chen, L. Ballni, Winston Chiu, Niels Cremers, Hugo Klaassen, Alexander Brown, Lorena Sánchez-Felipe, Arnaud Marchand, Patrick Chaltin, Pieter Leyssen, Johan Neyts, Manon Laporte	2025	0
2	Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models International Journal of Molecular Sciences ·Marlene Schwarzfischer, Marion Walker, Michele Curcio, César Díaz, Arnaud Marchand, ولی اله نظری, 坦利原, Marcin Wawrzyniak, Yasser Morsy, Silvia Lang, Marianne R. Spalinger, Matthias Versele, Michael Scharl	2025	0
3	Confusion About the Effusion: A Rare Presentation of Malignant Mesothelioma American Journal of Respiratory and Critical Care Medicine ·Marcelo Ferreira Zanin, Arnaud Marchand, Jannette Collins	2025	0
4	Mechanism of action of phthalazinone derivatives against rabies virus Antiviral Research ·Valentina Chegwin Dugand, Pedro Castells, Guillaume Bouvier, Guilherme Dias de Melo, E. Laffont, Yingbin Hua, Dirk Jochmans, Sophie Rogée, A J Echeverri, Lauriane Kergoat, 何华新, Tina Van Buyten, Nadia Izadi‐Pruneyre, Patrick Chaltin, Johan Neyts, Arnaud Marchand, Florence Larrous, Hervé Bourhy	2024	0
5	A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors Viruses ·Xinyu Wang, Winston Chiu, Hugo Klaassen, Arnaud Marchand, Patrick Chaltin, Johan Neyts, Dirk Jochmans	2023	2
6	The β2-adrenergic receptor in the apical membrane of intestinal enterocytes senses sugars to stimulate glucose uptake from the gut Frontiers in Cell and Developmental Biology ·Bobojon Pirmahmadzoda, 吉年斌, Frank Stolz, Eveline Lescrinier, Miroslav Popelka, Suzan Lambin, Arnaud Marchand, Patrick Chaltin, Pieter In 'T Veld, Mrs. Rana Ali Hussein, Jan Tavernier, Patrick Van Dijck, Walter Luyten, Johan M. Thevelein	2023	0
7	Identification of novel Ebola virus inhibitors using biologically contained virus Antiviral Research ·Bert Vanmechelen, Н.А. Остапенко, Winston Chiu, L. Ballni, Arnaud Marchand, Patrick Chaltin, Kurt Vermeire, Piet Maes	2022	6
8	Loratadine, an antihistaminic drug, suppresses the proliferation of endometrial stromal cells by inhibition of TRPV2 European Journal of Pharmacology ·Charlotte Van den Eynde, Katharina Held, 泰資白石, Katrien De Clercq, Sara Kerselaers, Arnaud Marchand, Patrick Chaltin, Thomas Voets, Joris Vriens	2022	11
9	Effective Small Molecule Antibacterials from a Novel Anti-Protein Secretion Screen Microorganisms ·Mohamed Belal Hamed, 亮牛渡, Fadoua Guezzi-Messaoud, Arnaud Marchand, Jozefien De Geyter, 陆玉林, Jozef Anné, Hugo Klaassen, Patrick Chaltin, Spyridoula Karamanou, Anastassios Economou	2021	1
10	A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin Antiviral Research ·Evelien Vanderlinden, Arnaud Marchand, フィデルカストロ, Hiroshi Takefuji, E Aromando, Hugo Klaassen, Leentje Persoons, Patrick Chaltin, Lieve Naesens	2021	6
11	Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development Antiviral Research ·Cheng Liu, Sandro Boland, Michael D. Scholle, Dorothée Bardiot, Arnaud Marchand, Patrick Chaltin, Lawrence M. Blatt, Leonid Beigelman, Julian Symons, Pierre Raboisson, Zachary A. Gurard‐Levin, Koen Vandyck, Jérôme Deval	2021	39
12	Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors Journal of Medicinal Chemistry ·Dorothée Bardiot, Yingbin Hua, Chen-Yu Zhou, Pascal Dieudonné Roy-Ema, Michael McNaughton, Suzanne J. F. Kaptein, Kai Dallmeier, Patrick Chaltin, Johan Neyts, Arnaud Marchand	2018	48
13	Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects Nature Communications ·Cyril Corbet, Estelle Bastien, Nihed Draoui, Bastien Doix, Lionel Mignion, Bénédicte F. Jordan, Arnaud Marchand, Jean‐Christophe Vanherck, Patrick Chaltin, Olivier Schakman, Holger M. Becker, Olivier Riant, Olivier Féron	2018	145
14	Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa PLoS ONE ·Sudiksha Aggrawal, Eline Blommaert, Francisco Serra, Alex J. O’Neill, Denise L. Williams, Dries De Maeyer, Ana Carolina Fierro, Kathleen Marchal, Arnaud Marchand, Patrick Chaltin, Pascal Spincemaille, Katrijn De Brucker, Karin Thevissen, Bruno P.A. Cammue, Toon Swings, Veerle Liebens, Maarten Fauvart, Natalie Verstraeten, Jan Michiels	2016	34
15	Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth Molecular Cancer Therapeutics ·Christine Helsen, Arnaud Marchand, Patrick Chaltin, Sebastian Munck, Arnout Voet, Annemieke Verstuyf, Frank Claessens	2012	13
16	Identification and characterization of 4-[4-(3-phenyl-2-propen-1-yl)-1-piperazinyl]-5H-pyrimido[5,4-b]indole derivatives asSalmonellabiofilm inhibitors FEMS Immunology & Medical Microbiology ·Stijn Robijns, T.K. Chukayeva, N Erkek Atay, Arnaud Marchand, Patrick Chaltin, Sigrid C. J. De Keersmaecker, Jos Vanderleyden, Hans Steenackers	2012	5
17	Pre-clinical evaluation of HIV replication inhibitors that target the HIV-integrase-LEDGF/p75 interaction Journal of the International AIDS Society ·Chris Pickford, Frauke Christ, Stephen M. Shaw, Kevin Whitby, Belete A. Desimmie, Caroline Smith‐Burchnell, Scott Butler, Arnaud Marchand, Patrick Chaltin, Zeger Debyser, Mike Westby	2011	3
18	Synthesis and in vitro evaluation of 2-amino-4-N-piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agents Bioorganic & Medicinal Chemistry Letters ·Steven De Jonghe, Arnaud Marchand, Ling‐Jie Gao, Zi'an Jia, Raif CERGİBOZAN, Ilse Sienaert, Jean Herman, Gavin Clydesdale, Hassan Sefrioui, Yuan Lin, Wolfgang Pfleiderer, Mark Waer, Piet Herdewijn	2010	20
19	Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase Anti-Cancer Drugs ·Anna Kruczynski, Abu-Baker NN, Arnaud Marchand, Stéphane Vispé, Emmanuel Fournier, Patrick Ruch, Diane Dees, Jean‐Marc Barret, Georges Delsol, Thierry Imbert, Jacques Fahy, Christian Bailly	2009	6
20	Synthesis and Antiviral Evaluation of Unnatural β-L-Enantiomers of 3′-Fluoro- and 3′-Azido-2,3′-dideoxyguanosine Derivatives Nucleosides Nucleotides & Nucleic Acids ·Arnaud Marchand, Christophe Mathé, Jean‐Louis Imbach, Gilles Gosselin	2000	6

About Arnaud Marchand

Arnaud Marchand is a scholar working on Virology, Infectious Diseases, Molecular Medicine, Microbiology and Sensory Systems, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Biochemical and Molecular Research (9 papers), HIV Research and Treatment (9 papers), Bacterial biofilms and quorum sensing (6 papers), Synthesis and Biological Evaluation (5 papers), Cytomegalovirus and herpesvirus research (5 papers), DNA and Nucleic Acid Chemistry (4 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Virology (443 citations), Infectious Diseases (603 citations), Sensory Systems (91 citations), Molecular Biology (825 citations) and Organic Chemistry (277 citations). Arnaud Marchand has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Patrick Chaltin, Frauke Christ, Zeger Debyser, Belete A. Desimmie, Dorothée Bardiot, Karin Thevissen, Bruno P.A. Cammue, Arnout Voet, Stefan Nicolet and Barbara Van Remoortel. Their work appears in journals such as Antiviral Research, Nucleosides Nucleotides & Nucleic Acids, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact